Is chemotherapy safe for children? — how it differs from adults

Yes — chemotherapy is routinely used to treat childhood cancers and is considered safe when given under the supervision of a trained paediatric oncologist. Children are not simply small adults; their bodies metabolise medicines differently, and the doses and drug combinations used in children are carefully calculated for age, weight, and body surface area. Paediatric chemotherapy regimens have been developed and refined over decades through large international clinical trials conducted specifically in children. The goal is always to use the minimum effective dose that controls the cancer while protecting as many healthy cells as possible. Your oncologist will explain which medicines your child needs and what side effects to watch for, and the team will monitor your child closely throughout treatment.

Paediatric chemotherapy differs from adult chemotherapy in several important ways. First, children are given age- and weight-specific doses — not scaled-down adult doses — because their organs (especially the liver and kidneys) process medicines at rates that change with age. Second, the cancer types that occur in children are biologically different from adult cancers; for example, childhood leukaemias are far more responsive to treatment than most adult leukaemias. Third, the drug combinations (called protocols or regimens) used in children are chosen from paediatric-specific evidence built up through decades of children's cancer clinical trials. Finally, the long-term side effects that matter most in children — effects on growth, learning, fertility, and heart function — are different from adult concerns, so paediatric protocols are designed to reduce these specifically.

Common short-term side effects during paediatric chemotherapy include nausea and vomiting, fatigue, mouth sores, reduced appetite, and temporary hair loss. Because chemotherapy affects rapidly dividing cells, the bone marrow is also affected — this reduces the number of blood cells temporarily, making children more vulnerable to infection, anaemia, and unusual bruising or bleeding during treatment. These effects are temporary and the team manages them actively with anti-nausea medicines, growth factors, and careful monitoring. Longer-term effects can include effects on heart function, hearing, kidney health, fertility, and learning, depending on which medicines are used. Your oncologist will explain which risks are relevant for your child's specific regimen and what follow-up monitoring is needed after treatment ends.

Hair loss (alopecia) is one of the most common and emotionally visible side effects of chemotherapy in children, but it is almost always temporary. Not all chemotherapy medicines cause hair loss — whether your child loses their hair depends on which medicines are used in their regimen. Hair that does fall out during treatment typically begins to grow back within a few weeks to months after the relevant medicines are stopped. Many families find that preparing children in advance — and involving them in choosing hats, scarves, or wigs if they wish — helps them feel more in control. The nurses and psycho-oncology team at CION support both children and parents through this part of the journey.

Chemotherapy doses for children are calculated using body surface area (a measurement derived from height and weight) rather than fixed adult doses. Before each cycle, the doctor or nurse checks your child's weight and adjusts the dose if needed. Blood tests are performed regularly — usually before every cycle — to check that the bone marrow has recovered sufficiently and that the liver and kidneys are handling the medicines well. If side effects are unexpectedly severe, the team can reduce the dose or delay a cycle. This close monitoring is one of the reasons children receive chemotherapy in specialist paediatric oncology settings rather than in general oncology units.

Many children can attend school for at least part of the time during chemotherapy, particularly in periods between cycles when their blood counts have recovered. Whether school attendance is safe depends on which phase of treatment your child is in, how their blood counts look, and whether there are any active infections in the school environment. The CION team will advise you week by week. During periods when blood counts are low, children are more vulnerable to infection, and the team may ask you to keep your child away from crowded places. Keeping as much normality as possible — school, friendships, play — is good for children's emotional health during treatment, and the team will help you find the right balance.